Join
Live feed
·
INSIDERFilingvia Quantisnow
Scopus BioPharma Inc. logo

SEC Form 4: Lamstein Joshua R bought $3,232 worth of Common Stock (800 units at $4.04), increasing direct ownership by 0.67% to 119,597 units

ByQuantisnow·Wall Street's wire, on your screen.
SCPS· Scopus BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCPS (Scopus BioPharma Inc.) and more on Quantisnow.